Cargando…
Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies
Background: Immunotherapy may be a rational strategy in leiomyosarcoma (LMS), a tumor known for its genomic complexity. As a prerequisite for therapeutic applications, we characterized the immune microenvironment in LMS, as well as its prognostic value. Methods: CD163(+) macrophages, CD3(+) T-cells,...
Autores principales: | Kostine, Marie, Briaire-de Bruijn, Inge H., Cleven, Arjen H. G., Vervat, Carly, Corver, Willem E., Schilham, Marco W., Van Beelen, Els, van Boven, Hester, Haas, Rick L., Italiano, Antoine, Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749622/ https://www.ncbi.nlm.nih.gov/pubmed/29308311 http://dx.doi.org/10.1080/2162402X.2017.1386828 |
Ejemplares similares
-
High nuclear expression of proteasome activator complex subunit 1 predicts poor survival in soft tissue leiomyosarcomas
por: Lou, Sha, et al.
Publicado: (2016) -
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
por: Sundara, Yayan T., et al.
Publicado: (2016) -
NTRK fusions are extremely rare in bone tumours
por: Lam, Suk Wai, et al.
Publicado: (2021) -
IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas
por: Cleven, Arjen H. G., et al.
Publicado: (2017) -
No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone
por: Peterse, Elisabeth F. P., et al.
Publicado: (2016)